Dr. Duan Weihong is a leading expert in China's hepatobiliary surgery field, renowned for pioneering ultra-high-difficulty surgeries that drive global medical advancements. During his tenure as Director of the Hepatobiliary Surgery Department at the Rocket Force Characteristic Medical Center, he led multiple breakthrough surgeries, including:
Ex vivo liver resection combined with autologous liver transplantation
Total hepatectomy combined with total pancreatectomy and allogeneic liver transplantation
Total pancreatectomy for advanced pancreatic cancer combined with small intestine resection and autologous intestinal transplantation
His achievements have positioned China at the international forefront of hepatobiliary oncology surgery, gaining global academic recognition.
For complex liver disease cases with vascular invasion, completed multiple cases of ex vivo liver resection and autologous liver transplantation; for biliary system tumor cases involving the liver and pancreas, performed total liver combined with total pancreas and spleen resection, and allogeneic liver transplantation.
For complex pancreatic cancer cases with arterial and venous invasion (previously considered inoperable), developed extended radical pancreatic cancer resection with small intestine autotransplantation—excising the pancreatic tumor, invaded blood vessels, and small intestine en bloc, removing the lesion ex vivo, and transplanting the remaining normal small intestine back into the body. Also includes procedures like "combined partial atrial resection, right hemihepatectomy, and resection of the invaded inferior vena cava with allogeneic vascular graft anastomosis." These cutting-edge techniques have significantly improved the radical resection rate of pancreatic cancer, achieving an R0 resection rate of over 80% in non-distant metastatic pancreatic cancer cases.
In the treatment of childhood hepatoblastoma, neuroblastoma, and nephroblastoma, completed internationally benchmark cases like "combined partial atrial resection, right hemihepatectomy, and resection of the invaded inferior vena cava with allogeneic vascular graft anastomosis," enabling surgical resection for many pediatric liver tumor patients who would otherwise require transplantation.
Particularly skilled in handling complex cases deemed "inoperable" by other institutions.
Leader of the Pediatric Complex Oncology Group of the Chinese Research Hospital Association
Member of the Pancreatic Study Group of the Beijing Medical Association
Member of the Hepatobiliary Committee of the PLA (People's Liberation Army)
Director of the Hepatobiliary Surgery Department, Chief Physician
Medical Doctorate: Shandong Medical University
Hepatobiliary Surgery, Rocket Force Characteristic Medical Center
Advanced Training: Visiting Scholar at Cleveland Clinic (USA), specializing in hepatobiliary oncology surgery
Led anatomical hands-on training at Southern Medical University and Shanxi Medical University to refine complex hepatopancreatic resection techniques.
Translational Anatomy: Established new anatomical protocols to guide complex surgeries
Oncology Therapeutics: Principal Investigator of national research projects, including:
"12th Five-Year Plan" National Major New Drug Creation Project
National Key R&D Program (focused on liver/pancreatic cancer)
Clinical Innovations: Awarded 3 patents for surgical instruments.
Mandarin (Native) / Medical English Proficiency
(Listed are major recent works across 4 key areas, totaling over 100 publications)
I. Hepatobiliary and Pancreatic Surgery Techniques and Complex Cases
Surgical Treatment of Complex Liver Tumors (2024, Shanghai Scientific and Technical Literature Press)l
Atlas and Analysis of Complex Hepatobiliary and Pancreatic Surgeries (2017, Science Press)l
Surgical Techniques and Anatomical Imaging Essentials for Hepatobiliary and Pancreatic Surgery (2018, Jilin University Press)l
Exploration and Practice of Robotic Minimally Invasive Surgery (2010, People's Military Medical Press)
II. Surgical Treatment and Complications Management of Pancreatic Cancer
Experience, Lessons, and Reflections on Severe Postoperative Complications in Hepatobiliary and Pancreatic Surgery (2019, World Book Publishing Company)l
Case Analysis of Hepatobiliary and Pancreatic Surgical Diseases (2010, Science Press)l
Surgical Experience in Treating Pancreatic Cancer with Simultaneous Invasion of Superior Mesenteric Artery and Vein (2022, Chinese Journal of Surgery)l
Surgical Reconstruction Methods for Pancreatic Cancer with Combined Arteriovenous Resection (2021, Chinese Journal of Pancreatology)l
Application of Isolated Pancreatico-Enteric Anastomosis in Mid-Advanced Pancreatic Cancer Surgery (2022, Chinese Journal of General Surgery)
III. Liver Surgery Techniques and Childhood Hepatoblastoma
Application of Glisson Pedicle Transection in Hepatectomy for Giant Middle Liver Tumors (2021, Chinese Journal of General Surgery)l
Value of Three-Dimensional Visual Reconstruction Technology in Hepatectomy for Complex Childhood Hepatoblastoma (2021, Journal of Clinical Hepatobiliary Diseases)
Application of Glisson Pedicle Transection Hepatectomy in Childhood Hepatoblastoma Resection (2021, Chinese Journal of Trauma and Repair (Electronic Edition))
1 Case of Extended Middle Hepatectomy with Preservation of S6 and Reconstruction of Intrahepatic V6 Vessels (2021, Asian Journal of Surgical Case Reports)
IV. Basic Anatomy and Minimally Invasive Treatment
Fundamentals of Space Anatomy and Clinical Applications (2017, Liaoning Science and Technology Press)l
Prognostic Factors Analysis of Laparoscopic Ultrasound-Guided Microwave Ablation for Liver Cancer (2021, Journal of Jinan University)l
Research Progress on the Characteristics and Clinical Applications of the Bare Area of the Liver and Surrounding Structures (2019, Chinese Journal of Clinical Anatomy)
1. Surgical Outcomes: Documented "good postoperative recovery" in high-risk cases
2. Clinical Reputation:
Patients travel across provinces for specialized treatment
Nationwide training of surgeons reflects industry authority
EN
CN
